Fill form to unlock content
Error - something went wrong!
Register now for full access to all the content
Thank you for registering!
For clinical researchers involved with COVID-19, understanding its impact on cardiovascular homeostasis and the underlying pathophysiology is essential. In this article, Dr. Lazar Mandinov, Sr. Medical Director at Parexel, outlines the most significant current evidence and uncertainties, and provides practical guidance for conducting clinical trials related to COVID-19.